116 related articles for article (PubMed ID: 18676251)
21. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
22. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
23. Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA.
Kroupis C; Stathopoulou A; Zygalaki E; Ferekidou L; Talieri M; Lianidou ES
Clin Biochem; 2005 Jan; 38(1):50-7. PubMed ID: 15607317
[TBL] [Abstract][Full Text] [Related]
24. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
25. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
Liao QP; Wu C; Zheng H; Yu L
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
[TBL] [Abstract][Full Text] [Related]
26. [F10 gene knock-down mediated by RNA interference induces apoptosis of KLE cells].
Cui YG; Quan S; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):317-9. PubMed ID: 18359680
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
28. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.
Favy DA; Rio P; Maurizis JC; Hizel C; Bignon YJ; Bernard-Gallon DJ
Biochem Biophys Res Commun; 1999 May; 258(2):284-91. PubMed ID: 10329379
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
30. [Effect of small interfering RNA targeting CXCR4 on breast cancer angiogenesis].
Li HY; Ren GS; Tan JX
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):954-8. PubMed ID: 19460719
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells.
Esteve JM; Armengod ME; Knecht E
Exp Cell Res; 2010 Oct; 316(16):2618-29. PubMed ID: 20599945
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range.
Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry AR
Biochimie; 2007 Oct; 89(10):1228-33. PubMed ID: 17509745
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
Favy DA; Rio PG; Vissac C; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
Anticancer Res; 2000; 20(3A):1703-4. PubMed ID: 10928095
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Calvo V; Beato M
Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 gene expression in breast cancer: a correlative study between real-time RT-PCR and immunohistochemistry.
Al-Mulla F; Abdulrahman M; Varadharaj G; Akhter N; Anim JT
J Histochem Cytochem; 2005 May; 53(5):621-9. PubMed ID: 15872055
[TBL] [Abstract][Full Text] [Related]
36. Role of BRCA1 in heat shock response.
Xian Ma Y; Fan S; Xiong J; Yuan RQ; Meng Q; Gao M; Goldberg ID; Fuqua SA; Pestell RG; Rosen EM
Oncogene; 2003 Jan; 22(1):10-27. PubMed ID: 12527903
[TBL] [Abstract][Full Text] [Related]
37. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
38. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of progesterone receptors A and B expressions in endometrial carcinomas].
Liao QP; Zheng H
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):616-9. PubMed ID: 15605094
[TBL] [Abstract][Full Text] [Related]
40. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
